Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600134646Phase 4Not yet recruiting
Phase 4, randomised trial of oxycodone (4 arms), sponsored by Quzhou People's Hospital. Primary endpoints: QoR-15/QoR-40 recovery quality scale score, Cortisol concentration and 11 more. Planned start Jul 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600134646.